Attitudes of patients and family members towards implantable psychiatric medication

Schizophrenia Research

Volumn 105, Issue 1-3, 2008, Pages 279-286

  Dankert, Mary E ^a,b   Brensinger, Colleen M ^a   Metzger, Kayla L ^a,b   Li, Chunbo ^c   Koleva, Svetlinka G ^d   Mesén, Andrea ^e   Laprade, Béatrice ^e   Wiguna, Tjhin ^f   Han, Changsu ^g   Farooq, Saeed ^h   Severus, W Emanuel ⁱ   Gayares, Jocelyn G ^j   Langosch, Jens M ^k   Lallart, Xavier ^l   Tateno, Masaru ^m   Mihai, Adriana ⁿ   Nair, Sudha R N ^o   Belmaker, Robert ^p   Rybakowski, Janusz ^q   Owe Larsson, Björn ^r   Kane, John M ^s   Johnstone, Eve C ^t   MacIntyre, Donald J ^t   Malhotra, Sameer ^u   González Pinto, Ana ^v   Mosquera, Fernando ^v   Babb, Suzann M ^w   pour, Ehsan Habib ^x   Fatemi, Seyedeh Sedigheh ^x   Swanson, Charles ^y   Adler, Caleb ^z   Young, Allan ^aa   Hoeft, Fumiko ^ab   Sivakumar, Kandiah ^u   Radoeva, Petya D ^b   Lallart, Elise A ^b   Bilker, Warren B ^a   Siegel, Steven J ^a,b   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TONGJI UNIVERSITY   (China)

^d Regional Dispensary for Mental Diseases with a Hospital Sofia City   (Bulgaria)

^e Center of Neuropsychiatric Studies of Costa Rica   (Costa Rica)

^f UNIVERSITY OF INDONESIA   (Indonesia)

^g Korea University College of Medicine   (South Korea)

^h LADY READING HOSPITAL   (Pakistan)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j University of St La Salle   (Philippines)

^k UNIVERSITY OF FREIBURG   (Germany)

^l Ville Evrard Psychiatric Hospital   (France)

^m SAPPORO MEDICAL UNIVERSITY   (Japan)

ⁿ UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^o CareLink Community Support Services   (United States)

^p BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^q POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^r KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^s ZUCKER HILLSIDE HOSPITAL   (United States)

^t UNIVERSITY OF EDINBURGH   (United Kingdom)

^u KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST   (United Kingdom)

^v Hospital Santiago   (Spain)

^w MCLEAN HOSPITAL   (United States)

^x MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^y UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^z UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^aa NEWCASTLE UNIVERSITY   (United Kingdom)

^ab STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adherence; Attitude; Drug implant; Family; Medication; Psychiatry; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; DEPRESSION; DRUG IMPLANT; FAMILY ATTITUDE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MOOD DISORDER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUPPORT GROUP;

EID: 52949133388     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.05.008     Document Type: Article

References (26)

1. Adams Jr. S.G., and Howe J.T. Predicting medication compliance in a psychotic population. J. Nerv. Ment. Dis. 181 9 (1993) 558-560
2. Archer D.F., Bigrigg A., Smallwood G.H., Shangold G.A., Creasy G.W., and Fisher A.C. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil. Steril. 77 2 Suppl 2 (2002) S27-S31
3. Asch D.A., Jedrziewski M.K., and Christakis N.A. Response rates to mail surveys published in medical journals. J. Clin. Epidemiol. 50 10 (1997) 1129-1136
4. Bergen J., Hunt G., Armitage P., and Bashir M. Six-month outcome following a relapse of schizophrenia. Aust. N. Z. J. Psychiatry 32 6 (1998) 815-822
5. Bosveld-van Haandel L.J., Slooff C.J., and van den Bosch R.J. Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments. Acta Psychiatr. Scand. 103 5 (2001) 335-346
6. Casper E.S., and Regan J.R. Reasons for admission among six profile subgroups of recidivists of inpatient services. Can. J. Psychiatry 38 10 (1993) 657-661
7. Cramer J.R., and Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr. Serv. 49 2 (1998) 196-201
8. Diagnostic and Statistical Manual of Mental Disorders. IV, text Revision ed.: The American Psychiatric Association, 2000.
9. Dixon L., Stewart B., Burland J., Delahanty J., Lucksted A., and Hoffman M. Pilot study of the effectiveness of the family-to-family education program. Psychiatr. Serv. 52 7 (2001) 965-967
10. Fox C. Questionnaire development. J. Health Soc. Policy 8 1 (1996) 39-48
11. Grond S., Zech D., Lehmann K.A., Radbruch L., Breitenbach H., and Hertel D. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 69 1-2 (1997) 191-198
12. Hogan T.P., Awad A.G., and Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 13 1 (1983) 177-183
13. Irani F., Dankert M., Brensinger C., Bilker W.B., Nair S.R., Kohler C.G., Kanes S.J., Turetsky B.I., Moberg P.J., Ragland J.D., Gur R.C., Gur R.E., and Siegel S.J. Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology 29 5 (2004) 960-968
14. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., and Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 63 10 (2002) 892-909
15. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., and Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353 12 (2005) 1209-1223
16. McLaughlin G. SMOG grading: a new readability formula. J. Read. 12 (1969) 639-646
17. Metzger K.L., Shoemaker J.M., Kahn J.B., Maxwell C.R., Liang Y., Tokarczyk J., Kanes S.J., Hans M., Lowman A.M., Dan N., Winey K.I., Swerdlow N.R., and Siegel S.J. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology 190 2 (2007) 201-211
18. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 24 1 (1986) 67-74
19. Moul, J.W. and Civitelli, K. 2001. Managing advanced prostate cancer with Viadur (leuprolide acetate implant). Urol Nurs 21(6): 385-388, 393-384; quiz 395-386.
20. Rabin C., Liang Y., Ehrlichman R.S., Budhian A., Metzger K.L., Majewski-Tiedeken C., Winey K.I., and Siegel S.J. In vitro and in vivo demonstration of risperidone implants in mice. Schizophr. Res. 98 1-3 (2008) 66-78
21. Rittmannsberger H., Pachinger T., Keppelmuller P., and Wancata J. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr. Serv. 55 2 (2004) 174-179
22. Siegel S.J., Winey K.I., Gur R.E., Lenox R.H., Bilker W.B., Ikeda D., Gandhi N., and Zhang W.X. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology 26 6 (2002) 817-823
23. Siegel S.J., Kahn J.B., Metzger K., Winey K.I., Werner K., and Dan N. Effect of drug type on the degradation rate of PLGA matrices. Eur. J. Pharm. Biopharm. 64 3 (2006) 287-293
24. Valenstein M., Copeland L.A., Owen R., Blow F.C., and Visnic S. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J. Clin. Psychiatry 62 7 (2001) 545-551
25. Viguera A.C., Baldessarini R.J., Hegarty J.D., van Kammen D.P., and Tohen M. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch. Gen. Psychiatry 54 1 (1997) 49-55
26. Weiden P.J., and Olfson M. Cost of relapse in schizophrenia. Schizophr. Bull. 21 3 (1995) 419-429